Hypertension With updated guidelines from AAFP - PowerPoint PPT Presentation

1 / 48
About This Presentation
Title:

Hypertension With updated guidelines from AAFP

Description:

Review the AAFP/JNC VII diagnostic criteria for hypertension. Review various treatment options, indications and side ... AAFP monograph: #305. HTN True or False ... – PowerPoint PPT presentation

Number of Views:349
Avg rating:5.0/5.0
Slides: 49
Provided by: omar8
Category:

less

Transcript and Presenter's Notes

Title: Hypertension With updated guidelines from AAFP


1
HypertensionWith updated guidelines from AAFP
JNC VII
  • Omar A. Khan, MD MHS
  • January 2006

2
Objectives
  • Review the AAFP/JNC VII diagnostic criteria for
    hypertension
  • Review various treatment options, indications and
    side effects

3
Fast Facts about Hypertension in the US
  • Hypertensive population 42,000,000
  • Controlled hypertensives 27
  • Those unaware of Dx 13,000,000
  • Aware but untreated 7,000,000
  • Of those treated 58 uncontrolled

4
JNC VII
5
JNC VII
6
JNC 7 Classification and Management of Blood
Pressure for Adults
JNC 7. May 2003. NIH publication 03-5233.
7
Diagnostic Workup
8
CVD Risk Factors
  • HTN
  • Obesity
  • Hyperlipidemia
  • Diabetes
  • Cigarette Smoking
  • Inactivity
  • Age
  • gt55 in men
  • gt65 in women
  • Fam history of premature CVD

9
(No Transcript)
10
(No Transcript)
11
JNC 7 Treatment Algorithm for Hypertension
Lifestyle modifications
SBPsystolic blood pressure DBPdiastolic blood
pressure ACEIangiotensin- converting enzyme
inhibitor ARBangiotensin receptor blocker
BBb-blocker CCBcalcium channel blocker JNC 7.
May 2003. NIH publication 03-5233.
12
Compelling Indications
  • Heart Failure
  • Post- MI
  • High CVD risk
  • DM
  • CRF
  • Cr gt 1.5 in men
  • Cr gt 1.3 in women
  • S/P CVA
  • Thiazide/loop, BB, ACEi, ARB, Aldosterone
    antagonist
  • BB, ACE, Aldosterone antagonist
  • Thiazide, BB, ACE, Ca channel blocker
  • Thiazide, BB, ACE, ARB, CCB
  • ACE, ARB. For creatinine 2-3 try loop diuretic
  • Thiazide, ACE inhibitor

13
Lifestyle Modifications to Manage HTN
Source The Seventh Report of the Joint National
Committee on Prevention, Detection, Evaluation,
and Treatment of High Blood Pressure JNCVII.
JAMA. 20032892560-2572.
14
Failures of Patient Education
  • 50 of patients discontinue their
    anti-hypertensive within 1 year of initiating
    treatment.
  • DASH diet for hypertension
  • limit sodium
  • Increase fruits and vegetables (8-10/d)
  • Increase low fat dairy (3-4/d)
  • Focus on diet history for hypertensive patients

15
Key Diet History Questions for Patients with HTN
  • Do you use a salt shaker?
  • Do you taste your food before you add salt?
  • How often do you eat salty foods, such as chips,
    pretzels, salted nuts, canned and smoked foods?
  • Do you read labels for sodium content?
  • How many servings of fruits and vegetables do you
    eat everyday?
  • How often do you eat or drink dairy products?
    What kind?
  • How often do you eat out? What kinds of
    restaurants?
  • Do you like to drink alcohol? How much?
  • How often do you exercise, including walking?

16
TIPS on drugs for HT
  • CCB OK for isolated systolic hypertension (ISH)
  • For DM ACEi or ARB with or without diuretic,
    then add BB or CCB
  • When ACEi causes cough, substitute ARB
  • Dont use short acting CCB (increases deaths due
    to arrhythmias).
  • Alpha blockers (e.g. clonidine) only as second
    line (more side effects).

17
  • Most patients should start with a diuretic as
    they enhance the effectiveness of other agents.
  • Most patients will require more than one agent.
  • Add a baby aspirin to improve cardiovascular
    outcomes.

18
Special Populations
  • Blacks have greater prevalence, severity, and
    impact and poorer response to monotherapy. ACE
    induced angioedema is more common
  • Estrogen containing oral contraceptives elevate
    BP. Aldomet, BB, and vasodilators OK in pregnancy
  • Higher prevalence, ISH more common, more frequent
    complications from ACE, CCB
  • Minorities
  • Women
  • Aged

19
Thiazides
  • Chlorothiazide (Diuril)
  • Chlorthalidone
  • Hydrochlorthiazide(Microzide,
  • Hydrodiuril)
  • Polythiazide (Renese)
  • Indapamide (Lozol)
  • Metolazone (Mykrox, Zaroxolyn)

All trade / brand / generic names are specific
to the USA
20
Benefits of Thiazide Diuretics
  • Evidence-based support for end points that matter
    (prevention of CV and all-cause mortality).
  • Reduced calcium excretion is a potential benefit
    for osteoporosis prevention.

21
Loop Diuretics
  • Bumetanide (Bumex)
  • Furosemide (Lasix)
  • Torsemide (Demadex)

Potassium-sparing Diuretics
  • Amiloride (Midamor)
  • Triamterene (Dyrenium)

All trade / brand / generic names are specific
to the USA
22
Aldosterone Receptor Blockers
  • Eplerone (Inspra)
  • Spironolactone (Aldactone)

Combined alpha- and beta- blockers
  • Carvedilol (Coreg)
  • Labetalol (Normodyne, Trandate)

All trade / brand / generic names are specific
to the USA
23
Beta-blockers
  • Atenolol (Tenormin)
  • Betaxolol (Kerlone)
  • Bisoprolol (Zebeta)
  • Metoprolol (Lopressor, Toprol XL)
  • Nadolol (Corgard)
  • Propranolol (Inderal/XL)
  • Timolol (Blocadren)

All trade / brand / generic names are specific
to the USA
24
ACE inhibitors
  • Benzapril (Lotensin)
  • Captopril (Capoten)
  • Enalpril (Vasotec)
  • Fosinopril (Monopril)
  • Lisinopril (Prinivil, Zestril)
  • Moexipril (Univasc)
  • Perindopril (Aceon)
  • Quinapril (Accupril)
  • Ramipril (Altace)
  • Trandolapril (Mavik)

All trade / brand / generic names are specific
to the USA
25
Angiotensin II Receptor Blockers
  • Candesartan (Atacand)
  • Eprosartan (Tevetan)
  • Irbesartan (Avapro)
  • Losartan (Cozaar)
  • Olmesartan (Benicar)
  • Telmisartan (Micardis)
  • Valsartan (Diovan)

All trade / brand / generic names are specific
to the USA
26
Calcium channel blockers
  • Dihydropyridines
  • Amlodipine (Norvasc)
  • Felodipine (Plendil)
  • Isradipine (Dynacirc CR)
  • Nicardipine (Cardene SR)
  • Nifedipine (Adalat CC, Procardia XL)
  • Nisoldipine (Sular)
  • DHPs can have negative inotropic effects, unlike
    non-DHPs, so use with caution in pts with
    impaired cardiac function

27
Calcium channel blockers
  • non-Dihydropyridines
  • Diltiazem (Cardizem CD, Dilacor XR, Tiazac,
    Cardizem LA)
  • Verapamil (Calan SR, Isoptin SR)

All trade / brand / generic names are specific
to the USA
  • DHPs can have negative inotropic effects, unlike
    non-DHPs, so use with caution in pts with
    impaired cardiac function

28
Alpha1 blockers
  • Doxazosin (Cardura)
  • Prazosin (Minipress)
  • Terazosin (Hytrin)

All trade / brand / generic names are specific
to the USA
29
Direct Vasodilators
  • Hydralazine (Apresoline)
  • Minoxidil (Loniten)

All trade / brand / generic names are specific
to the USA
30
Centrally acting drugs
  • Clonidine (Catapres)
  • Methyldopa (Aldomet)
  • Reserpine (generic)
  • Guanfacine (generic)

All trade / brand / generic names are specific
to the USA
31
Again Treatment Algorithm
32
References
  • JNC 7 report available via NIH (Publication
    03-5233)
  • JAMA 289 (19), May 21 2003 (online)
  • AAFP monograph 305

33
HTN True or False
  • ACE Inhibitors should be initial drug therapy for
    most, either alone or combined with other drug
    classes.

34
False
  • ACE Inhibitors Thiazides should be initial drug
    therapy for most, either alone or combined with
    other drug classes.

35
True or False
  • For persons over age 50, DBP is more important
    than SBP as CVD risk factor.

36
False
  • For persons over age 50, SBP is a more important
    than DBP as CVD risk factor.

37
True or False
  • Normal blood pressure is defined as SBP lt 135 and
    DBP lt 90.

38
False
  • Normal blood pressure is defined as SBP lt 120 and
    DBP lt 80. People with SBP 120 139 OR DBP 80
    89 should be considered prehypertensive.

39
True or False
  • Those people whose BP is classified as
    prehypertensive should be initially treated with
    lifestyle modification from the time they are
    identified.

40
True
  • Those people whose BP is classified as
    prehypertensive should be initially treated with
    lifestyle modification from the time they are
    identified.

41
  • Key lifestyle modification measures that, if
    initiated in all prehypertensive and hypertensive
    individuals, are likely to lower BP, include all
    except..
  • a) Weight reduction
  • b) DASH Eating Plan
  • c) Smoking cessation
  • d) Dietary sodium reduction
  • e) Physical activity
  • f) Moderation of alcohol intake

42
  • Key lifestyle modification measures that should
    be initiated in all prehypertensive and
    hypertensive individuals in order to lower BP
    include all except..
  • a) Weight reduction
  • b) DASH Eating Plan
  • c) Smoking cessation
  • d) Dietary sodium reduction
  • e) Physical activity
  • f) Moderation of alcohol intake

43
True or False
  • If BP is gt20/10 mmHg above goal, initiate
    therapy with a single agent and lifestyle
    modification.

44
False
  • False. If BP is gt20/10 mmHg above goal, initiate
    therapy with two agents, one usually should be a
    thiazide-type diuretic.

45
True or False
  • Self measurement can help assess white-coat HTN.

46
True
  • Self measurement can help improve adherence with
    therapy, provide helpful information on response
    to therapy and assist in assessing white-coat
    HTN.

47
True or False
  • Most patients will only require one
    antihypertensive drug to achieve goal BP.

48
False
  • Most patients will require 2 or more
    antihypertensive drugs to achieve goal BP
Write a Comment
User Comments (0)
About PowerShow.com